Skip to main content
SpringerLink
Log in

Transmission, Medical Consequences, and Prevention/Treatment of COVID-19 Infection

  • Protocol
  • First Online:
In Silico Modeling of Drugs Against Coronaviruses

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

  • 788 Accesses

Abstract

A novel coronavirus named as Severe Acute Respiratory Syndrome Coronavirus 2019 (SARS-CoV-2) emerged in the city of Wuhan, China, during December 2019. This virus spread quickly across the globe and posed Public Health Emergency, which was declared as a global pandemic during March 2020 by the World Health Organization (WHO). Until now, several characteristics of SARS-CoV-2 are not confirmed such as exact mode of transmission, animal origins, and antiviral therapeutics. However, it is now well known that this virus infects lungs, causes difficulties in breathing process, and affects taste and smell. The disease caused by SARS-CoV-2 is known as coronavirus disease 2019 (COVID-19). Despite all the investigations and strategies developed, it is deemed necessary that new protocols should be launched for the development and evaluation of vaccines and therapeutics. In this chapter, we discuss the spread and/or transmission of SARS-CoV-2 and the associated complications. Moreover, we summarize the therapeutic and prevention options and the most salient features of COVID-19.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY (2016) Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov 15:327–347. https://doi.org/10.1038/nrd.2015.37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192. https://doi.org/10.1038/s41579-018-0118-9

    Article  CAS  PubMed  Google Scholar 

  3. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24:490–502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Forni D, Cagliani R, Clerici M, Sironi M (2017) Molecular evolution of human coronavirus genomes. Trends Microbiol 25:35–48

    Article  CAS  PubMed  Google Scholar 

  5. Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M (2020) The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. J Clin Microbiol 58:e00187–e00120. https://doi.org/10.1128/JCM.00187-20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Khan S, Ali A, Siddique R, Nabi G (2020) Novel coronavirus is putting the whole world on alert. J Hosp Infect 104:252. https://doi.org/10.1016/j.jhin.2020.01.019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ji W, Wang W, Zhao X, Zai J, Li X (2020) Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol 92:433–440. https://doi.org/10.1002/jmv.25682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chen Y, Liu Q, Guo D (2020) Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423. https://doi.org/10.1002/jmv.25681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91:264–266. https://doi.org/10.1016/j.ijid.2020.01.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lin CY, Peng YC, Wu YH, Chang J, Chan CH, Yang DY (2007) The psychological effect of severe acute respiratory syndrome on emergency department staff. Emerg Med J 24:12–17. https://doi.org/10.1136/emj.2006.035089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, El Sheikh S, Alsanouri T (2013) Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. EMHJ 19(Supp 1):S12–S18

    PubMed  Google Scholar 

  13. Bukhari EE, Temsah MH, Aleyadhy AA, Alrabiaa AA, Alhboob AA, Jamal AA, Binsaeed AA (2016) Middle east respiratory syndrome coronavirus (MERS-CoV) outbreak perceptions of risk and stress evaluation in nurses. J Infect Dev Ctries 10:845–850. https://doi.org/10.3855/jidc.6925

    Article  PubMed  Google Scholar 

  14. Lee SM, Kang WS, Cho AR, Kim T, Park JK (2018) Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry 87:123–127. https://doi.org/10.1016/j.comppsych.2018.10.003

    Article  PubMed  PubMed Central  Google Scholar 

  15. Khan S, Siddique R, Li Z, Xue M, Liu J (2020) COVID-19 pandemic; prevention, treatment, and mental health. Hum Vaccin Immunother 16:2215–2216. https://doi.org/10.1080/21645515.2020.1759976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Khan S, Nabi G, Han G, Siddique R, Lian S, Shi H, Bashir N, Ali A, Shereen MA (2020) Novel coronavirus: how the things are in Wuhan. Clin Microbiol Infect 26:399. https://doi.org/10.1016/j.cmi.2020.02.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Khan S, Siddique R, Li H, Ali A, Adnan M, Bashir N, Xue M (2020) Impact of coronavirus outbreak on psychological health. J Glob Health 10:1–6. https://doi.org/10.7189/jogh.10.010331

    Article  Google Scholar 

  18. Khan S, Liu J, Xue M (2020) Transmission of SARS-CoV-2, required developments in research and associated public health concerns. Front Med 7:1–8. https://doi.org/10.3389/fmed.2020.00310

    Article  CAS  Google Scholar 

  19. Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol 92:552–555. https://doi.org/10.1002/jmv.25728

    Article  CAS  PubMed  Google Scholar 

  20. Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Nerosci 11:995. https://doi.org/10.1021/acschemneuro.0c00122

    Article  CAS  Google Scholar 

  21. Qian Z, Travanty EA, Oko L, Edeen K, Berglund A, Wang J, Ito Y, Holmes KV, Mason RJ (2013) Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol 48:742–748. https://doi.org/10.1165/rcmb.2012-0339OC

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Raj VS, Mou H, Smits SL, Dekkers DHW, Müller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, Thiel V, Drosten C, Rottier PJM, Osterhaus ADME, Bosch BJ, Haagmans BL (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251–254. https://doi.org/10.1038/nature12005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:278. https://doi.org/10.1038/s41586-020-2012-7

    Article  CAS  Google Scholar 

  24. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276–278

    Article  CAS  PubMed  Google Scholar 

  25. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, de Wit E, Munster VJ, Hensley LE, Zalmout IS, Kapoor A (2014) Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5:e00884–e00814

    PubMed  PubMed Central  Google Scholar 

  26. Provincial G, Health P, Hospital WJ, Hospital B (2020) Full genome NJ tree all CoV families Maximum likelihood tree of all outbreak sequences with orf1a region 2020-01-23 All outbreak sequences so far are very closely

    Google Scholar 

  27. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W (2020) Commentary genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27:325–328. https://doi.org/10.1016/j.chom.2020.02.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fu B, Xu X, Wei H (2020) Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med 18:164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, Hu Y, Tao Z-W, Tian J-H, Pei Y-Y (2020) A new coronavirus associated with human respiratory disease in China. Nature 579:265–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 6736:1–10. https://doi.org/10.1016/S0140-6736(20)30251-8

    Article  Google Scholar 

  31. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). StatPearls Publishing, Treasure Island, FL

    Google Scholar 

  32. Dong N, Yang X, Ye L, Chen K, Chan EW-C, Chen S (2020) Genomic and protein structure modelling analysis depicts the origin and pathogenicity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. F1000Res 9:121

    Article  CAS  Google Scholar 

  33. Boulant S, Stanifer M, Lozach P-Y (2015) Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis. Viruses 7:2794–2815. https://doi.org/10.3390/v7062747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. White JM, Whittaker GR (2016) Fusion of enveloped viruses in endosomes. Traffic 17:593–614. https://doi.org/10.1111/tra.12389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 106:5871–5876. https://doi.org/10.1073/pnas.0809524106

    Article  PubMed  PubMed Central  Google Scholar 

  36. Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3:237–261. https://doi.org/10.1146/annurev-virology-110615-042301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, Wang X (2017) Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res 27:119–129. https://doi.org/10.1038/cr.2016.152

    Article  CAS  PubMed  Google Scholar 

  38. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M (2020) COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol 92:584

    Article  CAS  PubMed  Google Scholar 

  39. Lei J, Kusov Y, Hilgenfeld R (2018) Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antiviral Res 149:58–74

    Article  CAS  PubMed  Google Scholar 

  40. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, Team CNCI and R (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sarris J, Kavanagh DJ (2009) Kava and St. John’s Wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med 15:827–836

    Article  PubMed  Google Scholar 

  42. WHO (2020) Level R, Level G, High V (2020) Coronavirus disease 2019 (COVID-19). WHO, Geneva

    Google Scholar 

  43. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X (2020) Articles Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, Wölfel R, Hoelscher M (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382:970. https://doi.org/10.1056/nejmc2001468

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, Xing F, Liu J, Yip CCY, Poon RWS, Tsoi HW, Lo SKF, Chan KH, Poon VKM, Chan WM, Ip JD, Cai JP, Cheng VCC, Chen H, Hui CKM, Yuen KY (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395:514–523. https://doi.org/10.1016/S0140-6736(20)30154-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061. https://doi.org/10.1001/jama.2020.1585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Wang L (2020) C-reactive protein levels in the early stage of COVID-19. Med Mal Infect 50:332–334. https://doi.org/10.1016/j.medmal.2020.03.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R (2004) SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis 10:1206–1212. https://doi.org/10.3201/eid1007.030703

    Article  PubMed  PubMed Central  Google Scholar 

  49. Khan S, Siddique R, Ali A, Xue M, Nabi G (2020) Novel coronavirus, poor quarantine, and the risk of pandemic. J Hosp Infect 104:449. https://doi.org/10.1016/j.jhin.2020.02.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Xiang Y-T, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH (2020) Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 0366:2019–2020. https://doi.org/10.1016/S2215-0366(20)30046-8

    Article  Google Scholar 

  51. Chiang JJ, Cole SW, Bower JE, Irwin MR, Taylor SE, Arevalo J, Fuligni AJ (2019) Brain, behavior, and immunity depressive symptoms and immune transcriptional profiles in late adolescents. Brain Behav Immun 80:163–169. https://doi.org/10.1016/j.bbi.2019.03.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Liu S, Yang L, Zhang C, Xiang Y, Liu Z, Hu S, Zhang B (2020) Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 7:e17–e18. https://doi.org/10.1016/S2215-0366(20)30077-8

    Article  PubMed  PubMed Central  Google Scholar 

  53. Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Xiang Y (2020) Mental health services for older adults in China during the COVID-19. Lancet Psychiatry 7:e19. https://doi.org/10.1016/S2215-0366(20)30079-1

    Article  PubMed  PubMed Central  Google Scholar 

  54. Liem A, Wang C, Wariyanti Y, Latkin CA, Hall BJ (2020) The neglected health of international migrant workers in the COVID-19. Lancet Psychiatry 7:e20. https://doi.org/10.1016/S2215-0366(20)30076-6

    Article  PubMed  PubMed Central  Google Scholar 

  55. Khan S, Nabi G, Yao L, Siddique R, Sajjad W, Kumar S, Duan P, Hou H (2018) Health risks associated with genetic alterations in internal clock system by external factors. Int J Biol Sci 14:791–798. https://doi.org/10.7150/ijbs.23744

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Zhou P, Fan H, Lan T, Yang X-L, Shi W-F, Zhang W, Zhu Y, Zhang Y-W, Xie Q-M, Mani S (2018) Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 556:255–258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Escobar-Viera CG, Whitfield DL, Wessel CB, Shensa A, Sidani JE, Brown AL, Chandler CJ, Hoffman BL, Marshal MP, Primack BA (2018) For better or for worse? A systematic review of the evidence on social media use and depression among lesbian, gay, and bisexual minorities. J Med Internet Res 20:1–14. https://doi.org/10.2196/10496

    Article  Google Scholar 

  58. Ruzek JI, Eric Kuhn E, Jaworski BK, Owen JE, Ramsey KM (2016) Mobile mental health interventions following war and disaster. mHealth 2:37. https://doi.org/10.21037/mhealth.2016.08.06

    Article  PubMed  PubMed Central  Google Scholar 

  59. Jones NM, Thompson RR, Schetter CD, Silver RC (2017) Distress and rumor exposure on social media during a campus lockdown. Proc Natl Acad Sci U S A 114:11663–11668. https://doi.org/10.1073/pnas.1708518114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323:1239. https://doi.org/10.1001/jama.2020.2648

    Article  CAS  PubMed  Google Scholar 

  61. Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD (2020) Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov 10:1121. https://doi.org/10.1158/2159-8290.CD-20-0596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. CDC (2020) People who are at higher risk for severe illness (older adults). https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html. Accessed 20 Apr 2020

  63. Schwartz DA, Graham AL (2020) Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 12:1–16. https://doi.org/10.3390/v12020194

    Article  Google Scholar 

  64. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y (2020) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 6736:1–7. https://doi.org/10.1016/S0140-6736(20)30360-3

    Article  Google Scholar 

  65. Khan S, Jun L, Nawsherwan SR, Li Y, Han G, Xue M, Nabi G, Liu J (2020) Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women. Clin Microbiol Infect 26:788. https://doi.org/10.1016/j.cmi.2020.03.034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Dong L, Tian J, He S, Zhu C, Wang J, Liu C, Yang J (2020) Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 323:1846–1848. https://doi.org/10.1001/jama.2020.4621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK, Team WS 2019-nCoV CI (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929. https://doi.org/10.1056/NEJMoa2001191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio 9:e00221. https://doi.org/10.1128/mBio.00221-18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Gao J, Tian Z, Yang X (2020) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14:72–73. https://doi.org/10.5582/bst.2020.01047

    Article  CAS  PubMed  Google Scholar 

  70. Ng CS, Kasumba DM, Fujita T, Luo H (2020) Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent cell death. Cell Death Differ 27:2363. https://doi.org/10.1038/s41418-020-0509-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain J-M, Brouqui P, Raoult D (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 56:105949. https://doi.org/10.1016/j.ijantimicag.2020.105949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269. https://doi.org/10.1038/s41422-020-0282-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 11:222. https://doi.org/10.1038/s41467-019-13940-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Chen C, Huang J, Cheng Z, Wu J, Chen S, Zhang Y, Chen B, Lu M, Luo Y, Zhang J, Yin P, Wang X (2020) Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. MedRxiv. https://doi.org/10.1101/2020.03.17.20037432

  75. Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395:e30–e31. https://doi.org/10.1016/S0140-6736(20)30304-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ (2020) Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35:e79. https://doi.org/10.3346/jkms.2020.35.e79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Mitjà O, Clotet B (2020) Use of antiviral drugs to reduce COVID-19 transmission. Lancet Glob Health 8:e639

    Article  PubMed  PubMed Central  Google Scholar 

  78. Shang L et al (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395:683–684. https://doi.org/10.1016/S0140-6736(20)30361-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Chan JFW, Lau SKP, To KKW, Cheng VCC, Woo PCY, Yuen K-Y (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465–522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Khan S, Siddique R, Bai Q, Shabana LY, Xue M, Nabi G, Liu J (2020) Coronaviruses disease 2019 (COVID-19): causative agent, mental health concerns, and potential management options. J Infect Public Health. https://doi.org/10.1016/j.jiph.2020.07.010

  81. Khan S, Siddique R, Li Z, Xue M, Liu J, Nabi G (2020) COVID-19 pandemic; prevention, treatment, and mental health. Hum Vaccin Immunother 16:2215–2216. https://doi.org/10.1080/21645515.2020.1759976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Wohlford-Lenane CL, Meyerholz DK, Perlman S, Zhou H, Tran D, Selsted ME, McCray PB (2009) Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol 83:11385–11390

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Wiley JA, Richert LE, Swain SD, Harmsen A, Barnard DL, Randall TD, Jutila M, Douglas T, Broomell C, Young M (2009) Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One 4:e7142. https://doi.org/10.1371/journal.pone.0007142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Mubarak A, Alturaiki W, Hemida MG (2019) Middle east respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development. J Immunol Res 2019:6491738. https://doi.org/10.1155/2019/6491738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China

    Suliman Khan, Rabeea Siddique & Aigerim Bizhanova

Authors
  1. Suliman Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rabeea Siddique
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aigerim Bizhanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India

    Kunal Roy

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Khan, S., Siddique, R., Bizhanova, A. (2021). Transmission, Medical Consequences, and Prevention/Treatment of COVID-19 Infection. In: Roy, K. (eds) In Silico Modeling of Drugs Against Coronaviruses. Methods in Pharmacology and Toxicology. Humana, New York, NY. https://doi.org/10.1007/7653_2020_57

Download citation

  • DOI: https://doi.org/10.1007/7653_2020_57

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1365-8

  • Online ISBN: 978-1-0716-1366-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation